Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of HCP1303 for benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• HCP1303

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED